Xiaodong Luo
9PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Sep 09, 2024
Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.Fredrik N Albach, Christian Geier, Christian Keicher
|Apr 29, 2023
An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.Luis Querol, Richard A Lewis, Hans-Peter Hartung
|Jun 23, 2022
A MCP-Mod approach to designing and analyzing survival trials with potential non-proportional hazards.Xiaodong Luo, Yuan Sun, Zhixing Xu
|Jul 28, 2020
Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.Jin Jin, Marie-Karelle Riviere, Xiaodong Luo
|Jul 07, 2020
Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.Bo Huang, Lu Tian, Zachary R McCaw
|Aug 28, 2019
Design and monitoring of survival trials based on restricted mean survival times.Xiaodong Luo, Bo Huang, Hui Quan
Pageof 2
Frequent Collaborators
1 joint publications
Hui Quan
1 joint publications
Bo Huang
1 joint publications
Zachary R McCaw
1 joint publications
Toni K Choueiri
1 joint publications
Dae Hyun Kim
1 joint publications
Jin Jin
1 joint publications
Luis Querol
1 joint publications
Richard A Lewis
1 joint publications
Hans-Peter Hartung
1 joint publications
Pieter A Van Doorn
